🇺🇸 FDA
Patent

US 9999591

Immunogenic composition against Campylobacter jejuni

granted A61KA61K2039/55505A61K2039/6037

Quick answer

US patent 9999591 (Immunogenic composition against Campylobacter jejuni) held by United States of America as represented by the Secretary of the Air Force expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/55505, A61K2039/6037, A61K31/715, A61K39/105